Droseffik 0.02 mg - 3 mg film-coat. tabl.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Drospirenone 3 mg (pink tablet); Ethinylestradiol 0,02 mg (pink tablet); Placebo (white tablet)

Disponible depuis:

EFFIK Benelux SA-NV

Code ATC:

G03AA12

DCI (Dénomination commune internationale):

Drospirenone; Ethinylestradiol; Placebo

Dosage:

0,02 mg - 3 mg

forme pharmaceutique:

Film-coated tablet

Composition:

Drospirenone 3 mg; Ethinylestradiol 0.02 mg; Placebo

Mode d'administration:

Oral use

Domaine thérapeutique:

Drospirenone and Ethinylestradiol

Descriptif du produit:

CTI code: 428407-01 - Pack size: 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-02 - Pack size: 2 x 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-03 - Pack size: 3 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224122 - CNK code: 2995744 - Delivery mode: Medical prescription; CTI code: 428407-04 - Pack size: 6 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224139 - CNK code: 2995751 - Delivery mode: Medical prescription; CTI code: 428407-05 - Pack size: 13 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224146 - CNK code: 2995769 - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: Yes

Date de l'autorisation:

2012-10-05